InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,436.44
(
-0.50%
)
US TECH 100
18,379.60
(
-0.95%
)
Dow Jones
40,743.33
(
0.50%
)
Brent Oil
78.57
(
-0.73%
)
Bitcoin
66,224.00
(
-0.90%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Au-530

Send PM Follow Ignore
Followers 1
Posts 428
Boards Moderated 0
Alias Born 06/03/2009

Au-530

Re: None

Monday, 11/09/2009 9:04:08 AM

Monday, November 09, 2009 9:04:08 AM

Post# of 80490
ARIA Bid 2.41 Ask 2.48 last 2.47 High 2.58 +.30 volume186k
JPMorgan Upgrades Ariad Pharmaceuticals, Inc. To Overweight
Posted on 11/09/09 at 6:59am
JPMorgan upgrades Ariad Pharmaceuticals, Inc. (Nasdaq: ARIA) to Overweight. The JPMorgan analyst raised ARIA price target to $6, Ariad closed just above $2 on Friday.
On JPMorgan's upgrade, Ariad Pharmaceuticals is trading up in the pre-market. The JPMorgan analyst raised his price target ahead of Ariad'spivotal late-stage data on sarcoma drug.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up